InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,610.00
(
0.00%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.18
(
-0.35%
)
Bitcoin
63,761.38
(
0.96%
)
Post# of 12
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ALERTS100%to10000%GAIN

Send PM Follow Ignore
Followers 1078
Posts 80316
Boards Moderated 8
Alias Born 03/10/2009

ALERTS100%to10000%GAIN

Member Level

Re: None

Wednesday, 02/07/2018 4:30:40 PM

Wednesday, February 07, 2018 4:30:40 PM

Post# of 12
GIDYL~~Our Approach,,Our revolutionary EndoBarrier® is a testament to the GI Dynamics mission. The first endoscopically inserted treatment for the management of type 2 diabetes and obesity. Both minimally invasive and completely reversible. EndoBarrier bridges the gap between pharmaceuticals and surgery by providing a safer and more effective way to control glucose and weight loss for individuals who are underserved by drugs and injections, but for whom surgery is not an option.

http://gidynamics.com/company/who-we-are/

STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up